PDE inhibitors exhibit anti-inflammatory activity by decreasing the levels of pro-inflammatory mediators and increasing the levels of anti-inflammatory cytokines, which are key players in the pathogenesis of inflammatory and autoimmune diseases. The gene discussed is ALDH7A1; the disease is autoimmune disease.